The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Therapeutic Targeting of Long Non-Coding RNAs in Cancer
Open accessAbstract
Long non-coding RNAs (lncRNAs) represent a significant population of the human transcriptome. Many lncRNAs exhibit cell and/or tissue/tumor specific expression making them excellent candidates for therapeutic applications. In this review we discuss examples of lncRNAs that demonstrate the diversity of their function in various cancer types. We also discuss recent advances in nucleic acid drug development with a focus on oligonucleotide-based therapies as a novel approach to inhibit tumor progression. The increased success rates of nucleic acid therapeutics provides an outstanding opportunity to explore lncRNAs as viable therapeutic targets to impact various aspects of cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–208 of 208
Zhang, H., Zheng, F., Yang, W., & Lu, J. (2017) · Gene · doi:10.1016/j.gene.2017.08.009 · Cited by 59
3S: Shotgun secondary structure determination of long non-coding RNAs
Novikova, I. V., Dharap, A. A., Hennelly, S. P., & Sanbonmatsu, K. Y. (2013) · Methods · doi:10.1016/j.ymeth.2013.07.030 · Cited by 57
Secondary structure impacts patterns of selection in human lncRNAs
Pegueroles, C., & Gabaldón, T. (2016) · BMC Biology · doi:10.1186/s12915-016-0283-0 · Cited by 53
Using Morpholinos to Control Gene Expression
Moulton, J. D. (2006) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc0430s27 · Cited by 52
A Hox-Embedded Long Noncoding RNA: Is It All Hot Air?
Selleri, L., Bartolomei, M. S., Bickmore, W. A., He, L., Stubbs, L. J., Reik, W., & Barsh, G. S. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006485 · Cited by 42
The PVT Gene Frequently Amplifies with MYC in Tumor Cells
Shtivelman, E., & Bishop, J. M. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.1148-1154.1989 · Cited by 40
Wu, H., Crooke, S., & Lima, W. (2007) · CRC Press eBooks · doi:10.1201/9780849387951-8 · Cited by 38
Antisense Oligonucleotide-mediated Knockdown in Mammary Tumor Organoids
Diermeier, S. D., & Spector, D. L. (2017) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2511 · Cited by 13
Self-citation
Cited by
The role of non-coding RNAs in oncology
Slack, F. J., & Chinnaiyan, A. M. (2019) · Cell · doi:10.1016/j.cell.2019.10.017 · Cited by 1,619
Noncoding RNA therapeutics—Challenges and potential solutions
Winkle, M., El-Daly, S. M., Fabbri, M., & Calin, G. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00219-z · Cited by 1,551
Ratti, M., Lampis, A., Ghidini, M., Salati, M., Mirchev, M. B., Valeri, N., & Hahne, J. C. (2020) · Targeted Oncology · doi:10.1007/s11523-020-00717-x · Cited by 606
Long non-coding RNAs: From disease code to drug role
Chen, Y., Li, Z., Chen, X., & Zhang, S. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.10.001 · Cited by 503
Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
Lu, Y., Chan, Y.-T., Tan, H.-Y., Li, S., Wang, N., & Feng, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01197-3 · Cited by 499
Metadata
- Authors
- Arun, G., Diermeier, S. D., & Spector, D. L.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 24
- Issue
- 3
- Pages
- 257-277
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2787895823
- Cited by
- 611
- References
- 208
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.